Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Company’s consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows:

(in thousands)	December 31, 2020		December 31, 2019
Cash and cash equivalents	$	42,147	$	8,344
Restricted cash	113		113
Total cash, cash equivalents and restricted cash	$	42,260	$	8,457

Schedule of Fair Value Assumptions Using Black-Scholes-Merton Option Pricing Model to Value Warrant Liabilities

The table below sets forth the assumptions used within the Black-Scholes-Merton option pricing model to value the Company’s warrant liabilities as of December 31, 2020:

Stock price	$	12.33
Exercise price	$	7.63
Time until expiration (years)	3.3
Expected volatility	75%
Risk-free interest rate	0.2%
Expected dividend yield	—%

Schedule of Antidilutive Securities Excluded from Computations of Diluted Earnings (Loss) Per Common Share

The following table summarizes the securities that were antidilutive (including warrants, UPOs, RSUs and preferred stock, if any, after giving effect to their respective conversion to shares of common stock for those units in-the-money, or share equivalents for those units out-of-the-money) and therefore, were not included in the computations of diluted earnings (loss) per common share.

	For the Years Ended
	December 31, 2020	December 31, 2019
In-the-money warrants	—	—
Out-of-the-money warrants	4,576,799	4,576,799
Preferred stock	—	—
Service-based RSUs	7,471	80,718
Performance and market-based RSUs (1)	276	375
Employee stock purchase plan	3,217	—
In-the-money UPOs	—	—
Out-of-the-money UPOs	—	15,067
Total	4,587,763	4,672,959

(1) For the years ended December 31, 2020 and 2019, certain PRSUs (defined below) and MRSUs were not included in the computation of diluted loss per share because the performance and market conditions were not satisfied during 2020 and 2019 and would not be satisfied if the reporting date was at the end of the contingency period.

Schedule of Computations of Diluted Earnings (Loss) Per Common Share

	For the Years Ended
(in thousands, except per share amounts)	December 31, 2020		December 31, 2019
EPS numerator:
Net income (loss)	$	5,807	$	(1,775)
EPS denominator:
Weighted average shares outstanding – basic	7,865		7,662
Nonvested restricted stock units	191		—
Employee stock purchase plan	9		—
Weighted average shares outstanding – diluted	8,065		7,662
Net income (loss):
Basic	$	0.74	$	(0.23)
Diluted	$	0.72	$	(0.23)